| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 719667 | 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one | 0.0392716453377535 | -0.070253622 |
| NSC 726217 | Combretastatin A4-analogue | 0.0392716453377535 | 0.29570357 |
| NSC 732936 | 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline | 0.0392716453377535 | 0.22483855 |
| NSC 734949 | 4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide | 0.0392716453377535 | 0.10316857 |
| NSC 743433 | 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one | 0.0392716453377535 | 0.07523534 |
| NSC 748147 | 5-methyl-2-{[(2)-3-phenylprop-2-enoyl]amino}benzamide | 0.0392716453377535 | 0.12354394 |
| NSC 748902 | [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] | 0.0392716453377535 | 0.24084605 |
| NSC 752506 | 5-nitro-N-((pyridin-3-yl)methyl)furan-2-carboxamide | 0.0392716453377535 | 0.2910138 |
| NSC 753377 | 3-[2-(1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine | 0.0392716453377535 | 0.26721279 |
| NSC 753598 | Null | 0.0392716453377535 | 0.02021269 |